AU2002247945A1 - Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof - Google Patents

Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof

Info

Publication number
AU2002247945A1
AU2002247945A1 AU2002247945A AU2002247945A AU2002247945A1 AU 2002247945 A1 AU2002247945 A1 AU 2002247945A1 AU 2002247945 A AU2002247945 A AU 2002247945A AU 2002247945 A AU2002247945 A AU 2002247945A AU 2002247945 A1 AU2002247945 A1 AU 2002247945A1
Authority
AU
Australia
Prior art keywords
manufacture
venlafaxine hydrochloride
crystalline polymorphs
polymorphs
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002247945A
Inventor
Virendra Kumar Agarwal
Satish Champaklal Manakiwala
Kanwal Pandita
Gaurang Balkrushna Patel
Mahesh Shankarbhai PATEL
Pankaj Ramanbhai Patel
Nirogi Venkata Satya Ramakrishna
Sonak Bhavin Rameshchandra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zydus Lifesciences Ltd
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Publication of AU2002247945A1 publication Critical patent/AU2002247945A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2002247945A 2001-12-13 2002-03-19 Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof Abandoned AU2002247945A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1177/MUM/2001 2001-12-13
IN1177MU2001 2001-12-13
PCT/IN2002/000046 WO2003050074A1 (en) 2001-12-13 2002-03-19 Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof

Publications (1)

Publication Number Publication Date
AU2002247945A1 true AU2002247945A1 (en) 2003-06-23

Family

ID=11097336

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002247945A Abandoned AU2002247945A1 (en) 2001-12-13 2002-03-19 Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof

Country Status (2)

Country Link
AU (1) AU2002247945A1 (en)
WO (1) WO2003050074A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
TW200523258A (en) * 2003-10-02 2005-07-16 Wyeth Corp Process for the preparation of 1-[cyano(phenyl)methyl]-cyclohexanol compounds
DE10359154A1 (en) 2003-12-16 2005-07-28 Krka Tovarna Zdravil, D.D. Process for the preparation of venlafaxine and venlafaxine hydrochloride Form I
WO2006035457A1 (en) * 2004-09-17 2006-04-06 Amoli Organics Ltd. A process for the manufacture of venlafaxine and intermediates thereof
CN100364966C (en) * 2005-04-14 2008-01-30 上海雅本化学有限公司 Process of synthesizing 1-[2-amino-1-(p-methoxylphenyl)-ethyl] cyclohexanol formate
WO2008038146A2 (en) * 2006-07-14 2008-04-03 Medichem, S.A. Improved processes for preparing vanlafaxine base and salts thereof
CN104529797A (en) * 2014-12-05 2015-04-22 南昌市博泽康医药科技有限公司 Preparation of venlafaxine hydrochloride chiral crystal form
CN112920062B (en) * 2021-01-26 2024-04-02 合肥立方制药股份有限公司 Method for synthesizing venlafaxine by utilizing fixed bed hydrogenation equipment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761501A (en) * 1983-10-26 1988-08-02 American Home Products Corporation Substituted phenylacetamides
UA77145C2 (en) * 1997-11-05 2006-11-15 Wyeth Corp Extended release dosage formulation
CN1240206A (en) * 1999-06-17 2000-01-05 华东理工大学 Process for preparing 1[2-(dimethyamino)-1-(4-methoxyphenyl)ethyl] cyclohexanol hydrochloridumi
US20020143211A1 (en) * 2000-10-19 2002-10-03 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochlorid, processes for preparing thereof
WO2002036542A1 (en) * 2000-10-31 2002-05-10 Ciba Specialty Chemicals Holding Inc. Crystalline forms of venlafaxine hydrochloride
AU2001235970A1 (en) * 2000-12-07 2002-06-18 Dr. Reddy's Research Foundation Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation

Also Published As

Publication number Publication date
WO2003050074A1 (en) 2003-06-19

Similar Documents

Publication Publication Date Title
IL196287A0 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof
AU2003235435A1 (en) Crystalline forms of quetiapine hemifumarate
HUP0500753A3 (en) Crystalline forms of valacyclovir hydrochloride
HK1049912A1 (en) Method of fabricating head supporting member
AU1234002A (en) Crystalline forms of venlafaxine hydrochloride
HK1067123A1 (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and processes for their preparation
AU2002330453A1 (en) Crystals of hydroxynorephedrine derivative
AU2002305162A1 (en) Polymorphs of fexofenadine hydrochloride
AU2003245029A1 (en) Novel crystalline forms of donepezil hydrochloride
IL162255A0 (en) Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
HUP0700037A2 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
AU2002247945A1 (en) Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
IL159266A0 (en) Crystalline forms of fexofenadine and processes for the preparation thereof
AU2001235970A1 (en) Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation
AU2003262928A1 (en) Crystalline form of nateglinide and process for preparation thereof
AU2002357701A1 (en) Polymorphs of fexofenadine base
AU2003298725A1 (en) Preparation of metallotexaphyrins
AU2003300874A1 (en) Crystalline forms of gatifloxacin and processes for preparation
AU2002353803A1 (en) Direct resolution of racemic threo-methylphenidate hydrochloride
EP1238585B8 (en) Use of esterquats
AU2002360409A1 (en) Methods and intermediates for the synthesis of azepines
AU2002347399A1 (en) Venlafaxine hydrochloride polymorphs
AU2002237189A1 (en) New use of phencynonate hydrochloride
AU2002238356A1 (en) New use of phencynonate hydrochloride
AU2002355044A1 (en) Process for preparation of 2-aminotetralin derivatives and intermediates thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase